Stellaromics
Latest round
- Series B
Last raised
- Feb 2025
Total raised
- $80M
Investors
- 2
About Stellaromics
Based in Massachusetts, US, and founded in 2022 by Ye Fu, and Christopher Kroeger, Stellaromics provides the advancement of biomedical research by spearheading the development and application of 3D in situ multi-omic analysis technology. In February 2025, Stellaromics Inc. As of November 2023, Todd Dickinson operates as a Chief Executive Officer (CEO) of the company. Stellaromics Inc. is a creator of an in situ analysis technology has developed a system aimed at examining multi-omic information optically extracted from biological tissue. The company's tools are employed by utilizing a patented technology to detect high-resolution 3D transcription patterns in native biological tissue through hydrogel tissue chemistry. This approach enables researchers to explore thick tissue samples, map gene expression patterns, and maintain the spatial integrity and anatomical structure of the cells.
Who invested in Stellaromics
2 investors across 1 round
See all investors in Stellaromics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 11, 2025
Amount
$80M
Investors
Questions about Stellaromics
Who invested in Stellaromics?
Stellaromics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stellaromics raised?
Stellaromics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Stellaromics last raise money?
Stellaromics's most recent round on record is a Series B, in Feb 2025.
What does Stellaromics do?
Based in Massachusetts, US, and founded in 2022 by Ye Fu, and Christopher Kroeger, Stellaromics provides the advancement of biomedical research by spearheading the development and application of 3D in situ multi-omic analysis technology.
Where is Stellaromics headquartered?
Stellaromics is headquartered in Boston, US.
Which VCs invest in companies like Stellaromics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stellaromics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Stellaromics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.